Anemia, defined by a deficiency in red blood cells or hemoglobin, affects approximately 1.62 billion people worldwide, with the highest prevalence in preschool children, pregnant women, and the elderly. It manifests in various forms, such as iron …
Anemia, characterized by a deficiency in red blood cells or hemoglobin, is a significant global health concern affecting approximately 1.62 billion people. It has severe implications for cerebrovascular health, increasing the risk of strokes and …
Iron deficiency anemia (IDA) is a widespread condition affecting over 1.62 billion people globally, particularly among women of reproductive age and children. It results from low iron levels leading to decreased hemoglobin production, causing …
The article discusses various types of anemia, including Iron-Deficiency Anemia, Vitamin Deficiency Anemia, Aplastic Anemia, Hemolytic Anemia, and Sickle Cell Anemia, each with unique causes and treatments. Common symptoms of anemia include fatigue, …
Anemia is a common blood disorder marked by a deficiency of healthy red blood cells or hemoglobin, leading to inadequate oxygen distribution in the body. Symptoms include fatigue, weakness, and shortness of breath. Borderline anemia occurs when …
The article discusses the differences between anemia and thalassemia, two blood disorders with distinct causes and characteristics. Anemia is defined as a decrease in red blood cells or hemoglobin, leading to insufficient oxygen delivery to tissues, …
Thalassemia is an inherited blood disorder characterized by insufficient hemoglobin production, leading to anemia and symptoms like fatigue and shortness of breath. It is classified into two main types: alpha thalassemia, caused by defects in alpha …
Sickle Cell Thalassemia, also known as Sickle Beta Plus Thalassemia (HbS β+thal), is a genetic disorder affecting hemoglobin production, resulting from the combination of sickle cell and beta-thalassemia traits. This condition leads to the production …
The article provides essential information about polycythemia in newborns, which is classified into primary (polycythemia vera) and secondary types. It highlights that polycythemia is diagnosed when hemoglobin levels exceed 22 g/dL, with normal …
Hemochromatosis is a metabolic disorder marked by excessive iron accumulation in the body, potentially damaging vital organs like the liver, heart, and pancreas. It is often hereditary, particularly affecting individuals of Northern European descent, …
Thalassemia is an inherited blood disorder that results in reduced hemoglobin production, leading to various symptoms and complications, including fatigue and anemia. It primarily manifests as alpha or beta thalassemia, with severity ranging from …
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare blood disorder marked by the destruction of red blood cells due to a defect in protective surface proteins, leading to hemolysis and various complications, including kidney damage. PNH is caused by …
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder caused by a mutation in the PIGA gene, leading to the destruction of red blood cells and resulting in complications such as anemia, thrombosis, and significant fatigue. Fatigue in PNH …
Injectafer, or ferric carboxymaltose, is an innovative intravenous treatment for iron deficiency anemia (IDA), particularly for patients unable to tolerate oral iron supplements. This condition affects millions globally, leading to symptoms like …
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and severe blood disorder that primarily leads to symptoms such as dark urine due to the destruction of red blood cells, known as hemolysis. This condition mainly affects individuals aged 30 to 40 …
Hemolytic disease of the newborn (HDN), also known as erythroblastosis fetalis, is a serious blood disorder affecting newborns due to blood type incompatibility between the mother and fetus, primarily involving Rh-negative mothers and Rh-positive …
The article discusses the immunocompromised state in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and the increased risks associated with infections. PNH, caused by a genetic mutation affecting the immune system, leads to a heightened …
Thalassemia is a genetic condition marked by insufficient hemoglobin production, leading to anemia. Individuals with one mutated gene are carriers, known as having thalassemia trait or minor, typically experiencing mild symptoms. Carriers can pass …
Sickle cell anemia (SCA) is a hereditary blood disorder caused by a genetic mutation that leads to the production of abnormal hemoglobin (hemoglobin S), resulting in crescent-shaped red blood cells. This shape impairs oxygen transport and can block …
Sickle cell anemia is caused by a mutation in the HBB gene, leading to the production of hemoglobin S, which causes red blood cells to become rigid and sickle-shaped. Common symptoms include anemia, pain crises, jaundice, frequent infections, and …
Anemia is a condition characterized by a deficiency of red blood cells or hemoglobin, with common types including iron-deficiency anemia, vitamin B12 deficiency anemia, hemolytic anemia, and aplastic anemia. Symptoms often include fatigue, weakness, …
Sickle Cell Anemia (SCA) is a genetic blood disorder caused by abnormal hemoglobin S (HbS), resulting in rigid, sickle-shaped red blood cells that can block blood flow and lead to severe pain and complications. It is a form of Sickle Cell Disease …
Sickle Cell Disease (SCD) is an inherited blood disorder caused by the production of abnormal hemoglobin S, leading to rigid and sickle-shaped red blood cells. Symptoms include severe pain crises, chronic anemia, increased infection risk, jaundice, …
Warm autoimmune hemolytic anemia (WAIHA) is a type of anemia caused by the immune system mistakenly destroying red blood cells, primarily involving IgG antibodies that react at normal body temperature. It accounts for 80-90% of autoimmune hemolytic …
The article discusses the symptoms, impact, treatment options, and management of thalassemia in children. Key symptoms include fatigue, paleness, shortness of breath, dizziness, enlarged spleen and liver, delayed growth, and bone deformities. …
Injectafer (ferric carboxymaltose) is an injectable iron replacement therapy approved for treating iron deficiency anemia (IDA) in adults and children over one year. It is particularly useful for patients who do not respond well to oral iron …
